Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • CAPA Plan - BSI CE Mark Closeout
    • Index
    • Overview and Device Description
    • Information provided by the Manufacturer
    • Design and Manufacturing Information
    • GSPR
    • Benefit-Risk Analysis and Risk Management
    • Product Verification and Validation
      • Software
      • Artificial Intelligence
      • Cybersecurity
      • Usability and Human Factors Engineering
      • Clinical
        • Evaluation
        • Investigation
          • 🗄 Drafts
          • AFF_2026
          • AIHS4_2026
          • ALADIN 2026
          • AVASI_2026
          • AWOSI_2026
          • ICD_DXP_2026
          • Sant_Pau_2024
          • VH_clinical_2025
          • VH_triaje_2025
          • aEASI_HVN_2026
          • ADS TLD DAO 2025
          • agm-2026
          • AIHS4 2025
          • BI 2024
          • COVIDX EVCDAO 2022
          • DAO Derivación O 2022
          • DAO Derivación PH 2022
            • R-TF-015-004 Clinical investigation plan
            • R-TF-015-006 Clinical investigation report
            • R-TF-015-010 Annex E ISO 14155
          • IDEI 2023
          • MAN 2025
          • MC EVCDAO 2019
          • PH 2024
          • SAN 2024
      • Commissioning
    • Post-Market Surveillance
  • Legit.Health Plus Version 1.1.0.1
  • Legit.Health version 2.1 (Legacy MDD)
  • Legit.Health US Version 1.1.0.0
  • Legit.Health Utilities
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • BSI Non-Conformities
  • Pricing
  • Public tenders
  • Trainings
  • Legit.Health Plus Version 1.1.0.0
  • Product Verification and Validation
  • Clinical
  • Investigation
  • DAO Derivación PH 2022

DAO Derivación PH 2022

📄️ R-TF-015-004 Clinical investigation plan

Scope

📄️ R-TF-015-006 Clinical investigation report

Research Title

📄️ R-TF-015-010 Annex E ISO 14155

Applicability and scope

Previous
R-TF-015-010 Annex E ISO 14155
Next
R-TF-015-004 Clinical investigation plan
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI Labs Group S.L.)